SCHEMBL22207243

SCHEMBL22207243

Cn1c(C(=O)O)c(Cl)ccc1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.36
TSHR P16473 1/20 0.36
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
HSD17B10 Q99714 1/20 0.36
TP53 P04637 1/20 0.35
TDP1 Q9NUW8 2/20 0.35
CTSB P07858 1/20 0.35
CA12 O43570 1/20 0.34
BRD4 O60885 1/20 0.34
BRPF1 P55201 1/20 0.34
CA9 Q16790 1/20 0.34
KAT2B Q92831 1/20 0.34
BRD9 Q9H8M2 1/20 0.34
LMNA P02545 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GRIA2 P42262 2/20 0.33
GRIA4 P48058 2/20 0.33
HCAR2 Q8TDS4 1/20 0.33
NOTUM Q6P988 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12130341 0.72 SMN1; SMN2 (0.39) TSHRALDH1A1KDM4ETP53TDP1
SCHEMBL27341809 0.71 DPP4 (0.39) DPP4TSHRALDH1A1KDM4EHSD17B10
SCHEMBL22224593 0.70 BRPF1 (0.39) TSHRALDH1A1KDM4EHSD17B10TP53
SCHEMBL31667532 0.68 BRPF1 (0.38) TSHRALDH1A1KDM4EHSD17B10TP53
SCHEMBL22207153 0.68 BRPF1 (0.41) TSHRALDH1A1KDM4EHSD17B10CA12
SCHEMBL31667098 0.68 BRPF1 (0.34) ALDH1A1CA12BRD4BRPF1CA9
SCHEMBL24850345 0.67 ALDH1A1 (0.39) TSHRALDH1A1HSD17B10L3MBTL1KMT2A
SCHEMBL1431321 0.65 HTT (0.53) ALDH1A1KDM4ELMNAMEN1KMT2A
SCHEMBL22224637 0.65 BRPF1 (0.35) ALDH1A1KDM4ECA12BRD4BRPF1
SCHEMBL31666972 0.65 SMN1; SMN2 (0.36) ALDH1A1KDM4ETDP1CA12BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3908579-B1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH INC (US) 2023-12-27 EP disclosed
US-20220089568-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH, INC. 2022-03-24 US disclosed
EP-3908579-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS Janssen Biotech, Inc. (US) 2021-11-17 EP disclosed
CN-113574054-A Dihydroorotate dehydrogenase inhibitors 詹森生物科技公司 2021-10-29 CN disclosed
WO-2020144638-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH, INC. (US) 2020-07-16 WO disclosed
WO-2020144638-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH, INC. (US) 2020-07-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220089568-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS DHODH, DLD, DPYD DPP4 3014/4885TSHR 3632/4885ALDH1A1 53/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.